Clinical Trials
28 trialsResiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
National Institutes of Health Clinical Center (CC)
Periganglionic Resiniferatoxin for the Treatment of Intractable Pain Due to Cancer-induced Bone Pain
National Institutes of Health Clinical Center (CC)
CORD-MRI
Mersin University
MATCH
University of Texas Southwestern Medical Center
EPOOzo
Dr. Negrin University Hospital
PITAC
Institut Cancerologie de l'Ouest
Study to Assess Epidural Resiniferatoxin for the Treatment of Intractable Pain Associated With Advanced Cancer
Sorrento Therapeutics, Inc.
Prometra Post-Approval Study
Flowonix Medical
STIMPAL
Elsan
ZIDON
National Cancer Institute, Naples
Break-1
National Cancer Institute, Naples
Improving Outcomes and Lowering Costs by Integration of Primary Care Providers and Pain Medicine Physicians for Pain Pts
Rush University Medical Center
Prosper-001
Evolve Restorative Center
Phase 3 Study to Assess Resiniferatoxin vs Standard of Care for the Treatment of Intractable Cancer Pain
Sorrento Therapeutics, Inc.
Change the Dose Frequency of Controlled-Release Oxycodone to Refractory Pain
Fujian Cancer Hospital
COPE
Pfizer
Ilera
Children's Hospital of Philadelphia
Ropivacaine/Dexamethasone and 10% Lignocaine Injection in GPN Block for Intractable Cancer Pain
All India Institute of Medical Sciences
WAZA-ARY
Assistance Publique - Hôpitaux de Paris
Dexmedetomidine Addition to Morphine in Patients With Metastatic Cancer
Hotel Dieu de France Hospital
A Phase 1 Study of Substance P-Saporin in Terminal Cancer Patients With Intractable Pain
University of Texas Southwestern Medical Center
KETA-1
Haukeland University Hospital
UDOME
McGill University Health Centre/Research Institute of the McGill University Health Centre
Pilot Study Comparing Treatment With Dexmedetomidine to Midazolam for Symptom Control in Advanced Cancer Patients
Fraser Health
NP2 Enkephalin For Treatment of Intractable Cancer Pain
Diamyd Inc
KEPAL
Assistance Publique - Hôpitaux de Paris
KETADOL
Assistance Publique - Hôpitaux de Paris
Phase II Clinical Trial of Fentanyl Transdermal Matrix Patch, in the Management of Cancer Pain- Assessment of Effectiveness, Safety and Pharmacokinetics -
Janssen Pharmaceutical K.K.